Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Antiviral Research
|
June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay
Yohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Journal of Biomolecular Screening
|
November 17, 2011
Primary and secondary drug screening assays for Friedreich ataxia
M Grazia Cotticelli, Lynn Rasmussen, Nicole L Kushner, et al.
Research Square
|
May 7, 2026
A mouse model to study persistent fatigue
Adam J Janowski, Kazuhiro Hayashi, Ashley N Plumb, et al.
Journal of Biomolecular Screening
|
September 28, 2011
High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity
Sandlin P Seguin, Carrie W Evans, Miranda Nebane-Akah, et al.
Plos One
|
July 2, 2014
Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis
Carlos C Goller, Mehreen Arshad, James W Noah, et al.
Journal of Medicinal Chemistry
|
October 10, 2012
(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection
Blake P Moore, Dong Hoon Chung, Daljit S Matharu, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
Venkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
Journal of Medicinal Chemistry
|
September 23, 2014
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus
Chad E Schroeder, Tuanli Yao, Julie Sotsky, et al.
Plos One
|
October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics
W Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Antiviral Research
|
June 8, 2025
High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay
Yohanka Martinez-Gzegozewska, Lynn Rasmussen, N Miranda Nebane, et al.
Journal of Biomolecular Screening
|
November 17, 2011
Primary and secondary drug screening assays for Friedreich ataxia
M Grazia Cotticelli, Lynn Rasmussen, Nicole L Kushner, et al.
Research Square
|
May 7, 2026
A mouse model to study persistent fatigue
Adam J Janowski, Kazuhiro Hayashi, Ashley N Plumb, et al.
Journal of Biomolecular Screening
|
September 28, 2011
High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity
Sandlin P Seguin, Carrie W Evans, Miranda Nebane-Akah, et al.
Plos One
|
July 2, 2014
Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis
Carlos C Goller, Mehreen Arshad, James W Noah, et al.
Journal of Medicinal Chemistry
|
October 10, 2012
(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection
Blake P Moore, Dong Hoon Chung, Daljit S Matharu, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
Venkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
Journal of Medicinal Chemistry
|
September 23, 2014
Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus
Chad E Schroeder, Tuanli Yao, Julie Sotsky, et al.
Plos One
|
October 13, 2016
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics
W Joon Chung, Jennifer L Goeckeler-Fried, Viktoria Havasi, et al.
Biorxiv : the Preprint Server for Biology
|
August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Page
of 9